Jaume Mora Graupera

Jefe de Grupo Senior

Research group

Gomez-Gonzalez S, Llano J, Garcia-López M, Garrido- García A, Suñol M, Lemos I, Pérez-Jaume S, Salvador-Marcos N, Gene-Olaciregui N, Galán RA, Santa-María López V, Pérez-Somarriba M, Castañeda-Heredia A, Hinojosa J, Winter U, Moreira FB, Lubieniecki F, Vazquez V, Mora J, Cruz-Martínez O, Morales-La Madrid A, Perera A and Lavarino C EpiGe: A machine-learning strategy for rapid classification of medulloblastoma using PCR-based methyl-genotyping. iScience 2023. 26(9): 107598-107598.
Cristina Larrosa Espinosa, Mora J and Cheung NK Global Impact of Monoclonal Antibodies (mAbs) in Children: A Focus on Anti-GD2. Cancers 2023. 15(14): .
Reinal I, Ontoria-Oviedo I, Selva M, Casini M, Peiró-Molina E, Fambuena-Santos C, Climent AM, Balaguer J, Cañete A, Mora J, Raya Á and Sepúlveda P Modeling Cardiotoxicity in Pediatric Oncology Patients Using Patient-Specific iPSC-Derived Cardiomyocytes Reveals Downregulation of Cardioprotective microRNAs ANTIOXIDANTS 2023. 12(7): .

More Publications

Project name:: Subvenció per a la incorporació de personal de suport als grups de recerca, corresponent als anys 2023-2025
Leader: Jaume Mora Graupera
Funding entities:: Departament de Salut - Generalitat de Catalunya
Code: SLT028/23/000308
Starting - finishing date:: 2023 - 2025

Project name:: Contratos predoctorales de formación en investigación en salud_Beneficiari: Pablo Taboas
Leader: Jaume Mora Graupera
Funding entities:: Instituto de Salud Carlos III (ISCIII)
Code: FI21/00047
Starting - finishing date:: 2022 - 2025

Project name:: Influencia del contexto epigenético en la edad como factor pronóstico en Ewing Sarcoma
Leader: Jaume Mora Graupera
Funding entities:: Instituto de Salud Carlos III (ISCIII)
Code: PI20/00179
Starting - finishing date:: 2021 - 2023

More projects

New research facilities for studying children's cancer
Thursday, 25 May 2023
New facilities have been opened for the children's oncology laboratory of the Institut de Recerca Sant Joan de Déu - SJD Barcelona Children's Hospital to celebrate 20 years of research. These laboratories are unique in their exclusive dedication to pediatric tumors and have over 50 researchers who focus on the study of more than ten developmental tumors.
Researchers at IRSJD develop a method to predict the efficacy of a potent nanomedicine in a severe childhood cancer
Thursday, 23 February 2023
Researchers at IRSJD have developed a method that predicts the anticancer efficacy of nab-paclitaxel, a well-known nanomedicine, in mouse models, for treatment of Ewing sarcoma, a severe cancer affecting the bones and soft tissue of children and adolescents.
Scientists at IRSJD and IRB Barcelona develop a study model for Ewing sarcoma in the Drosophila fly
Friday, 7 October 2022
This novel model has come about from a close collaboration between the laboratories headed by Dr. Jaume Mora at Institut de Recerca Sant Joan de Déu (IRSJD) and SJD Barcelona Children’s Hospital, and Dr. Cayetano Gonzalez at the Institute for Research in Biomedicine (IRB Barcelona). The work has been published in the journal PNAS Nexus.

See All news

More activities